Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02917 (Long intergenic non-protein coding RNA 2917, abbreviated LINC02917) is an autonomously transcribed long non-coding RNA gene in humans, designated based on its genomic position and lack of overlap with protein-coding regions[1][5]. LINC02917 belongs to the family of long intergenic non-coding RNAs (lincRNAs), which are normally longer than 200 nucleotides and thought to serve regulatory roles in chromatin architecture, RNA stabilization, and the fine-tuning of gene expression through mechanisms such as transcriptional regulation and enhancer activity. As of now, LINC02917 has not been linked to particular diseases, biological pathways, or drug interactions, and its specific cellular functions remain undetermined.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2917 (LINC02917).